https://www.selleckchem.com/pr....oducts/jnk-inhibitor
ence was extremely rare; however, patients with any of these pathologic findings require careful follow-up. Healthcare policies have focused on centralizing care to high-volume centers in an effort to optimize patient outcomes; however, little is known about patients' and caregivers' considerations and selection process when selecting hospitals for care. We aim to explore how patients and caregivers select hospitals for complex cancer care and to develop a taxonomy for their selection considerations. This was a qualitative st
Like
Comment
Share
